The recognition of the impact of new medications and the synergic effect of new drug combinations is absent in studies comparing coronary artery bypass grafting surgery (CABG) with medical therapy. There are limited review data regarding the contribution of morbidities after CABG on outcomes.
No takes yet. Share an insight, caveat, or question.
A 2019 study studied this question.
Synapse has enriched 4 related papers. Consider them for comparative context: